Operating Expenses

R&D

Oracle R&D increased by 1.8% to $2.61B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $2.43B to $2.61B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 10.9% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ3 2026Mar 11, 2026

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

20 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Value$1.72B$1.68B$1.75B$1.82B$1.97B$2.09B$2.16B$2.15B$2.23B$2.22B$2.23B$2.25B$2.23B$2.31B$2.47B$2.43B$2.65B$2.49B$2.56B$2.61B
QoQ Change-1.8%+4.2%+3.5%+8.2%+6.5%+3.1%-0.6%+3.7%-0.4%+0.5%+1.0%-1.0%+3.6%+7.2%-1.7%+9.3%-6.1%+2.8%+1.8%
YoY Change+14.6%+24.3%+23.0%+18.2%+13.3%+5.9%+3.2%+4.8%+0.0%+4.1%+11.0%+8.1%+19.2%+8.0%+3.6%+7.3%
Range$1.68B$2.65B
CAGR+9.2%
Avg YoY Growth+10.5%
Median YoY Growth+8.0%
Current Streak2 quarters growth

Frequently Asked Questions

What is Oracle's r&d?
Oracle (ORCL) reported r&d of $2.61B in Q4 2025.
How has Oracle's r&d changed year-over-year?
Oracle's r&d increased by 7.3% year-over-year, from $2.43B to $2.61B.
What is the long-term trend for Oracle's r&d?
Over 4 years (2021 to 2025), Oracle's r&d has grown at a 10.9% compound annual growth rate (CAGR), from $6.53B to $9.86B.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.